Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study

Cord blood transplantation (CBT) is an effective option for treating hematological malignancies, but graft failure (GF) remains the primary cause of therapy failure. Thus, based on myeloablative conditioning (MAC) of busulfan with cyclophosphamide (Bu/Cy) or total body irradiation with Cy (TBI/Cy),...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Cancer
Hlavní autoři: Sun, Zimin, Liu, Huilan, Luo, Chenhui, Geng, Liangquan, Zheng, Changcheng, Tang, Baolin, Zhu, Xiaoyu, Tong, Juan, Wang, Xingbing, Ding, Kaiyang, Wan, Xiang, Zhang, Lei, Yao, Wen, Song, Kaiding, Zhang, Xuhan, Wu, Yue, Yang, Huizhi, Han, Yongsheng, Liu, Xin, Zhu, Weibo, Wu, Jingsheng, Wang, Zuyi
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Cancer Therapy and Prevention
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6033117/
https://ncbi.nlm.nih.gov/pubmed/29473150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31339
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky